Mitigation Efforts in Arsenic Exposure With Folic Acid Supplementation
Enrolling by invitation · Not applicable · Has a placebo group
Conditions studied: Arsenic and/or Arsenic Compound Adverse Reaction
In brief
The purpose of this study is to evaluate the effects on folic acid supplementation in a population living in an environment with chronic arsenic exposure in Birmingham, Alabama.
Key facts
- Study ID
- NCT05656664
- Run by
- University of Alabama at Birmingham
- People needed
- 100
- Starts
- 2023-09-14
- Expected to finish
- 2026-12-31
- Last updated by the study team
- 2026-04-30
Who can join
Age: 18 and older, up to 89. Sex: any. Healthy volunteers: accepted.
You may qualify if…
- ≥18 years of age
- Resident of the superfund site
- Clinically stable with no significant changes in general health status in the past 4 weeks prior to screening as assessed by the investigator
- Provide written informed consent
You may not qualify if…
- Pregnancy
- Ongoing folic acid nutritional supplementation
- Methotrexate use
- Megaloblastic anemia
- Alcoholic liver disease
- Malabsorptive syndromes - celiac disease, inflammatory bowel disease
Where it is running
- UAB Lung Health Center — Birmingham, Alabama, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.